Published in J Immunol on August 01, 1988
A novel, high-performance random array platform for quantitative gene expression profiling. Genome Res (2004) 4.32
Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci U S A (1989) 3.88
Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med (1992) 3.20
Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest (1996) 2.92
Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. EMBO J (1993) 2.75
Cytokines in asthma. Thorax (1999) 2.64
Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest (1996) 2.51
Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med (1997) 2.37
Antimicrobial peptides from human platelets. Infect Immun (2002) 2.32
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A (1999) 2.17
cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci U S A (1989) 2.13
Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol (1998) 2.09
Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues. J Exp Med (1995) 2.07
The human homolog of the JE gene encodes a monocyte secretory protein. Mol Cell Biol (1989) 1.95
Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol (1997) 1.88
Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med (1997) 1.67
Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells. J Exp Med (1997) 1.63
Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol (1995) 1.61
Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci U S A (2002) 1.61
Identification of RANTES receptors on human monocytic cells: competition for binding and desensitization by homologous chemotactic cytokines. J Exp Med (1993) 1.53
Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol (1998) 1.51
Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med (1994) 1.49
The human cytokine I-309 is a monocyte chemoattractant. Proc Natl Acad Sci U S A (1992) 1.47
Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. Nat Clin Pract Nephrol (2007) 1.43
Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol Cell Biol (1990) 1.33
CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. Proc Natl Acad Sci U S A (1998) 1.32
Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J Clin Invest (1998) 1.30
Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production. Infect Immun (1995) 1.30
Expression of the chemokine superfamily in rheumatoid arthritis. Clin Exp Immunol (1994) 1.22
Patterns for RANTES secretion and intercellular adhesion molecule 1 expression mediate transepithelial T cell traffic based on analyses in vitro and in vivo. J Exp Med (1998) 1.22
Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections. Am J Pathol (2005) 1.21
Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation. Infect Immun (1999) 1.17
Kruppel-like transcription factor 13 regulates T lymphocyte survival in vivo. J Immunol (2007) 1.16
Clustering of cytokine genes on mouse chromosome 11. J Exp Med (1990) 1.15
Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells (2014) 1.14
Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma. Am J Pathol (1996) 1.12
Immunoglobulin E plus antigen challenge induces a novel intercrine/chemokine in mouse mast cells. J Exp Med (1992) 1.12
Virus-inducible expression of a host chemokine gene relies on replication-linked mRNA stabilization. Proc Natl Acad Sci U S A (1999) 1.09
Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia. Infect Immun (2001) 1.08
A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes. J Clin Invest (2002) 1.08
Definition of a lipopolysaccharide-responsive element in the 5'-flanking regions of MuRantes and crg-2. Mol Cell Biol (1994) 1.07
Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10. Inflammation (2003) 1.06
Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection. Proc Natl Acad Sci U S A (1997) 1.03
Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis. Mediators Inflamm (2012) 1.01
Rabies virus-induced activation of mitogen-activated protein kinase and NF-kappaB signaling pathways regulates expression of CXC and CC chemokine ligands in microglia. J Virol (2005) 1.01
Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res (2009) 1.01
CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma. PLoS One (2012) 1.00
Large induction of the chemotactic cytokine RANTES during cutaneous wound repair: a regulatory role for nitric oxide in keratinocyte-derived RANTES expression. Biochem J (2000) 1.00
Novel expression pattern of a new member of the MIP-1 family of cytokine-like genes. Cell Regul (1991) 1.00
Upregulation of RANTES gene expression in neuroglia by Japanese encephalitis virus infection. J Virol (2004) 1.00
Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation. Mol Cell Biol (1996) 0.99
Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10 and -13. Immunology (1996) 0.99
Using guinea pigs in studies relevant to asthma and COPD. Pulm Pharmacol Ther (2008) 0.98
ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus. J Immunol (2009) 0.98
RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75. Br J Pharmacol (2006) 0.98
Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity. J Immunother (2009) 0.97
Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway. J Biol Chem (2010) 0.97
Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis? J Clin Pathol (2006) 0.96
Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase. J Biol Chem (2011) 0.95
Interleukin-12 expression is focally enhanced in the gastric mucosa of pediatric patients with Crohn's disease. Am J Pathol (1998) 0.94
CCL5 as a potential immunotherapeutic target in triple-negative breast cancer. Cell Mol Immunol (2013) 0.92
Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response. PLoS One (2012) 0.92
RANTES (CCL5) regulates airway responsiveness after repeated allergen challenge. Am J Respir Cell Mol Biol (2006) 0.92
Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes. Mol Cell Biol (2006) 0.92
Requirements for measles virus induction of RANTES chemokine in human astrocytoma-derived U373 cells. J Virol (1999) 0.92
Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis. Hum Reprod Update (2013) 0.91
Viral regulation of RANTES expression during human cytomegalovirus infection of endothelial cells. J Virol (2001) 0.90
Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs. Front Immunol (2015) 0.90
Analysis of T cell subsets and beta chemokines in patients with pulmonary sarcoidosis. Thorax (1997) 0.89
Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. FASEB J (2016) 0.87
In vivo expression of interleukin-8, and regulated on activation, normal, T-cell expressed, and secreted, by human germinal centre B lymphocytes. Immunology (2003) 0.87
Effects of the mTOR inhibitor rapamycin on monocyte-secreted chemokines. BMC Immunol (2014) 0.87
Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1 alpha (MIP-1 alpha), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD). Clin Exp Immunol (1999) 0.86
Interaction of PRP4 with Kruppel-like factor 13 regulates CCL5 transcription. J Immunol (2007) 0.84
Intrapersonal and populational heterogeneity of the chemokine RANTES. Clin Chem (2010) 0.84
Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy. J Clin Cell Immunol (2014) 0.83
The novel chemokine receptor, G-protein-coupled receptor 75, is expressed by islets and is coupled to stimulation of insulin secretion and improved glucose homeostasis. Diabetologia (2013) 0.83
The Fli-1 transcription factor regulates the expression of CCL5/RANTES. J Immunol (2014) 0.82
Regulated on activation, normal T-cell-expressed and -secreted mRNA expression in normal endometrium and endometriotic implants: assessment of autocrine/paracrine regulation by in situ hybridization. Am J Pathol (2001) 0.82
Regulation of CCL5 expression in smooth muscle cells following arterial injury. PLoS One (2012) 0.82
RANTES deficiency attenuates autoantibody-induced glomerulonephritis. J Clin Immunol (2010) 0.82
Phosphorylation of measles virus nucleoprotein affects viral growth by changing gene expression and genomic RNA stability. J Virol (2013) 0.81
Superantigen immune stimulation evokes epithelial monocyte chemoattractant protein 1 and RANTES production. Infect Immun (1999) 0.81
Deletion of cationic amino acid transporter 2 exacerbates dextran sulfate sodium colitis and leads to an IL-17-predominant T cell response. Am J Physiol Gastrointest Liver Physiol (2013) 0.81
Selective upregulation of immune regulatory and effector cytokine synthesis by intestinal intraepithelial lymphocytes following CD43 costimulation. Biochem Biophys Res Commun (2005) 0.81
Elevated levels of beta-chemokines in bronchoalveolar lavage fluid (BALF) of individuals infected with human T lymphotropic virus type-1 (HTLV-1). Clin Exp Immunol (1999) 0.81
Alzheimer's disease and HIV associated dementia related genes: I. location and function. Bioinformation (2008) 0.80
Mycoplasma gallisepticum lipid associated membrane proteins up-regulate inflammatory genes in chicken tracheal epithelial cells via TLR-2 ligation through an NF-κB dependent pathway. PLoS One (2014) 0.80
Chemokine research moves on. Exp Cell Res (2011) 0.79
Expression and purification of 15 kDa granulysin utilizing an insect cell secretion system. Protein Expr Purif (2010) 0.79
Mnk Kinases in Cytokine Signaling and Regulation of Cytokine Responses. Biomol Concepts (2012) 0.79
Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytes. Blood (2012) 0.79
Defensin and chemokine expression patterns in the palatine tonsil: a model of their local interaction. Eur Arch Otorhinolaryngol (2005) 0.78
Transcriptional profiling of experimental CD8(+) lymphocyte depletion in rhesus macaques infected with simian immunodeficiency virus SIVmac239. J Virol (2012) 0.78
Tails of the unexpected - an atypical receptor for the chemokine RANTES/CCL5 expressed in brain. Br J Pharmacol (2006) 0.78
A new approach to understanding T cell development: the isolation and characterization of immature CD4-, CD8-, CD3- T cell cDNAs by subtraction cloning. Mol Biol Cell (1992) 0.78
The protein phosphatase inhibitor calyculin A stimulates chemokine production by human synovial cells. Biochem J (1995) 0.77
Genes differentially regulated by NKX2-3 in B cells between ulcerative colitis and Crohn's disease patients and possible involvement of EGR1. Inflammation (2012) 0.77
Immunohistochemical study of monocyte chemoattractant protein-1 in the pancreas of NOD mice following cyclophosphamide administration and during spontaneous diabetes. J Mol Histol (2006) 0.76
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
The immunological synapse: a molecular machine controlling T cell activation. Science (1999) 17.41
Polymerase chain reaction with single-sided specificity: analysis of T cell receptor delta chain. Science (1989) 9.01
Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature (1984) 8.89
The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med (1992) 7.80
Association of hemolysin production, hemagglutination of human erythrocytes, and virulence for chicken embryos of extraintestinal Escherichia coli isolates. Infect Immun (1978) 7.28
Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci U S A (1982) 7.16
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med (1999) 6.09
Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins. Nature (1984) 6.08
Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B. J Clin Microbiol (1986) 5.19
An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02
Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell (1994) 4.60
The immunological synapse. Annu Rev Immunol (2001) 4.45
Somatic recombination in a murine T-cell receptor gene. Nature (1984) 4.21
The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol (1983) 4.17
Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature (1983) 4.16
Genomic organization and sequence of T-cell receptor beta-chain constant- and joining-region genes. Nature (1984) 4.15
Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature (1992) 4.01
An immunoglobulin heavy-chain gene is formed by at least two recombinational events. Nature (1980) 3.99
A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity (1999) 3.88
A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science (1998) 3.76
DNA sequences mediating class switching in alpha-immunoglobulins. Science (1980) 3.70
Induction of altered chromatin structures by simian virus 40 enhancer and promoter elements. Nature (1984) 3.68
RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet (1994) 3.64
Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity (2000) 3.49
Cell-type-specific cDNA probes and the murine I region: the localization and orientation of Ad alpha. Proc Natl Acad Sci U S A (1984) 3.43
The adult T-cell receptor delta-chain is diverse and distinct from that of fetal thymocytes. Nature (1988) 3.43
Antigen-specific development of primary and memory T cells in vivo. Science (1995) 3.41
Structural gene sets active in embryos and adult tissues of the sea urchin. Cell (1976) 3.38
CDR3 length in antigen-specific immune receptors. J Exp Med (1994) 3.35
Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol (1999) 3.33
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med (2000) 3.32
Differential clustering of CD4 and CD3zeta during T cell recognition. Science (2000) 3.30
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A (1999) 3.30
Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell (1989) 3.29
Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol (1984) 3.26
A third type of murine T-cell receptor gene. Nature (1984) 3.24
Immunoglobulin heavy chain gene organization in mice: analysis of a myeloma genomic clone containing variable and alpha constant regions. Proc Natl Acad Sci U S A (1979) 3.19
A new T-cell receptor gene located within the alpha locus and expressed early in T-cell differentiation. Nature (1987) 3.08
Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci U S A (1994) 3.07
Low affinity interaction of peptide-MHC complexes with T cell receptors. Science (1991) 2.89
Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J Immunol (1999) 2.89
T-cell receptor delta gene rearrangements in early thymocytes. Nature (1988) 2.88
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med (2000) 2.78
Structure, expression and divergence of T-cell receptor beta-chain variable regions. Nature (1984) 2.71
A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity (1996) 2.69
Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. Proc Natl Acad Sci U S A (1998) 2.69
The nature of major histocompatibility complex recognition by gamma delta T cells. Cell (1994) 2.64
Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med (1994) 2.61
Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science (1990) 2.56
Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. Immunity (1998) 2.52
Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. Proc Natl Acad Sci U S A (1982) 2.51
CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature (1995) 2.45
Some characteristics of Escherichia coli strains isolated from extraintestinal infections of humans. J Infect Dis (1978) 2.40
Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med (2000) 2.30
A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature (1990) 2.17
Kinetic discrimination in T-cell activation. Proc Natl Acad Sci U S A (1996) 2.17
Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J Immunol (1994) 2.15
Getting heavier, younger: trajectories of obesity over the life course. Int J Obes (Lond) (2009) 2.09
Promoter elements of genes coding for proteins and modulation of transcription by estrogens and progesterone. Recent Prog Horm Res (1984) 2.04
Identification of self through two-dimensional chemistry and synapses. Annu Rev Cell Dev Biol (2001) 1.99
Localization of a T-cell receptor diversity-region element. Nature (1984) 1.96
Molecular components of T-cell recognition. Annu Rev Immunol (1992) 1.96
Regulating the retention of T-cell receptor alpha chain variants within the endoplasmic reticulum: Ca(2+)-dependent association with BiP. J Cell Biol (1991) 1.93
Not without my permission: parents' willingness to permit use of newborn screening samples for research. Public Health Genomics (2009) 1.92
Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J Exp Med (1991) 1.92
Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor. Nature (1985) 1.89
Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J Immunol (1997) 1.85
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci U S A (2001) 1.85
Specificity of OKT4+ cytotoxic T lymphocyte clones. J Immunol (1982) 1.84
Identification and sequence of a fourth human T cell antigen receptor chain. Nature (1988) 1.81
HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes. Nature (1988) 1.78
Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol (2008) 1.76
Molecular genetics of the T cell-receptor beta chain. Annu Rev Immunol (1985) 1.76
Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8. Nature (1989) 1.76
Human cytolytic T lymphocyte interactions with vascular endothelium and fibroblasts: role of effector and target cell molecules. J Immunol (1984) 1.75
Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity (1998) 1.74
T cell assays and MIATA: the essential minimum for maximum impact. Immunity (2012) 1.74
LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation. J Immunol (1984) 1.72
Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J Infect Dis (2001) 1.72
Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol (1993) 1.70
An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. J Clin Endocrinol Metab (1974) 1.67
Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms. N Engl J Med (1985) 1.65
Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity (1996) 1.64
Experience with juvenile polyps in North American children: the need for pancolonoscopy. Am J Gastroenterol (2001) 1.61
Ligand-specific oligomerization of T-cell receptor molecules. Nature (1997) 1.58
The effects of MHC gene dosage and allelic variation on T cell receptor selection. Cell (1990) 1.58
Formation of a highly peptide-receptive state of class II MHC. Immunity (1998) 1.58
Expression of genes of the T-cell antigen receptor complex in precursor thymocytes. Nature (1985) 1.57
A murine T cell receptor gene complex: isolation, structure and rearrangement. Immunol Rev (1984) 1.56
T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med (1990) 1.55
A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity (1997) 1.55
Kinetics and extent of T cell activation as measured with the calcium signal. J Exp Med (1997) 1.51
Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2. Nature (1987) 1.50